RITUXIMAB AND SARGRAMOSTIM IMMUNOTHERAPY FOLLOWING AUTOLOGOUS STEM CELL TRANSPLANT FOR AGGRESSIVE NON-HODGKIN'S LYMPHOMA

被引:0
作者
Scigliano, E. [1 ]
Grosskreutz, C. L. [1 ]
Osman, K. [1 ]
Malone, A. [1 ]
Nieto, J. [1 ]
Isola, L. M. [1 ]
机构
[1] Mt Sinai Med Ctr, New York, NY 10029 USA
关键词
D O I
10.1016/j.bbmt.2009.12.167
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
136
引用
收藏
页码:S208 / S209
页数:3
相关论文
共 50 条
[31]   Autologous stem cell transplantation in follicular non-Hodgkin's lymphoma [J].
Pettengell, R .
BONE MARROW TRANSPLANTATION, 2002, 29 (Suppl 1) :S1-S4
[32]   Autologous stem cell transplantation in patients with non-Hodgkin's lymphoma [J].
Prinz, E ;
Mitterbauer, M ;
Keil, F ;
Kalhs, P ;
Mitterbauer, G ;
Höcker, P ;
Jäger, U ;
Chott, A ;
Mannhalter, C ;
Greinix, H .
BONE MARROW TRANSPLANTATION, 2001, 27 :S272-S272
[33]   Autologous Transplantation as Consolidation for Aggressive Non-Hodgkin's Lymphoma [J].
Stiff, Patrick J. ;
Unger, Joseph M. ;
Cook, James R. ;
Constine, Louis S. ;
Couban, Stephen ;
Stewart, Douglas A. ;
Shea, Thomas C. ;
Porcu, Pierluigi ;
Winter, Jane N. ;
Kahl, Brad S. ;
Miller, Thomas P. ;
Tubbs, Raymond R. ;
Marcellus, Deborah ;
Friedberg, Jonathan W. ;
Barton, Kevin P. ;
Mills, Glenn M. ;
LeBlanc, Michael ;
Rimsza, Lisa M. ;
Forman, Stephen J. ;
Fisher, Richard I. .
NEW ENGLAND JOURNAL OF MEDICINE, 2013, 369 (18) :1681-1690
[34]   Mucosal melanoma following autologous stem cell transplantation for non-Hodgkin's lymphoma (NHL) [J].
BenYosef, R ;
Braverman, I ;
Saah, D ;
Nagler, R ;
Shohat, S ;
Or, R ;
Nagler, A .
BONE MARROW TRANSPLANTATION, 1996, 18 (05) :1017-1019
[35]   Lines of therapy before autologous stem cell transplant and CAR-T affect outcomes in aggressive Non-Hodgkin's lymphoma [J].
Khurana, Arushi ;
Hathcock, Matthew ;
Habermann, Thomas M. ;
Al Saleh, Abdullah S. ;
Gandhi, Sangeetha ;
Truong, Tuan ;
Bennani, N. Nora ;
Paludo, Jonas ;
Villasboas, Jose C. ;
Ansell, Stephen M. ;
Inwards, David J. ;
Porrata, Luis F. ;
Johnston, Patrick B. ;
Micallef, Ivana ;
Lin, Yi .
AMERICAN JOURNAL OF HEMATOLOGY, 2021, 96 (10) :E386-E389
[36]   Rituximab and Interleukin 2 for CD20 positive Non-Hodgkin's Lymphoma following autologous transplant. [J].
Holmberg, LA ;
Maloney, DG ;
Bensinger, WI .
BLOOD, 2002, 100 (11) :646A-647A
[37]   Is autologous stem cell transplantation feasible in solid organ transplant recipients with non-Hodgkin's lymphoma? [J].
Jantunen, E. ;
Pyorala, M. ;
Kuittinen, T. ;
Mantymaa, P. ;
Koljonen, E. ;
Kuittinen, O. ;
Kuitunen, H. ;
Nousiainen, T. .
BONE MARROW TRANSPLANTATION, 2013, 48 :S421-S422
[38]   Effects of pretransplantation treatment with rituximab on outcomes of autologous stem-cell transplantation for non-Hodgkin's lymphoma [J].
Hoerr, AL ;
Gao, F ;
Hidalgo, J ;
Tiwari, D ;
Blum, KA ;
Mathews, V ;
Adkins, DR ;
Blum, W ;
Devine, S ;
Vij, R ;
Goodnough, LT ;
Dipersio, JF ;
Khoury, HJ .
JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (22) :4561-4566
[39]   Effects of pretransplantation treatment with rituximab on outcomes of autologous stem-cell transplantation for non-hodgkin's lymphoma [J].
Akhtar, S ;
Maghfoor, I .
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (25) :6261-6261
[40]   Lenalidomide and Rituximab Following Autologous Stem Cell Transplantation for B-Cell Non-Hodgkin Lymphoma Is Associated with Unacceptable Myelotoxicity [J].
Dean, Robert ;
Pohlman, Brad ;
Rybicki, Lisa ;
Maggiotto, Amanda L. ;
Bates, Jennifer ;
Smith, Stephen D. ;
Bolwell, Brian J. ;
Sweetenham, John .
BLOOD, 2011, 118 (21) :705-705